Attached files

file filename
EX-31.2 - EX-31.2 - Neos Therapeutics, Inc.a18-18987_1ex31d2.htm
EX-31.1 - EX-31.1 - Neos Therapeutics, Inc.a18-18987_1ex31d1.htm
10-Q - 10-Q - Neos Therapeutics, Inc.a18-18987_110q.htm

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Neos Therapeutics, Inc. for the quarterly period ended September 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Gerald McLaughlin, as President and Chief Executive Officer of Neos Therapeutics, Inc., hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Neos Therapeutics, Inc.

 

Date: November 9, 2018

By:

/s/ Gerald McLaughlin

 

 

Gerald McLaughlin

 

 

President and Chief Executive Officer

 

 

(Principal Executive Officer)

 

In connection with the Quarterly Report on Form 10-Q of Neos Therapeutics, Inc. for the quarterly period ended September 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Richard Eisenstadt, as Chief Financial Officer of Neos Therapeutics, Inc., hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Neos Therapeutics, Inc.

 

Date: November 9, 2018

By:

/s/ Richard Eisenstadt

 

 

Richard Eisenstadt

 

 

Chief Financial Officer (Principal Financial Officer)

 

1